DCM
ASLN
DAFNA Capital Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-343,720
| Closed | -$170K | – | 94 |
|
|
2022
Q2 | $170K | Buy |
343,720
+100,000
| +41% | +$49.5K | 0.05% | 88 |
|
|
2022
Q1 | $219K | Sell |
243,720
-488,780
| -67% | -$439K | 0.06% | 89 |
|
|
2021
Q4 | $820K | Hold |
732,500
| – | – | 0.21% | 69 |
|
|
2021
Q3 | $1.3M | Buy |
732,500
+55,000
| +8% | +$97.9K | 0.35% | 63 |
|
|
2021
Q2 | $2.24M | Hold |
677,500
| – | – | 0.47% | 46 |
|
|
2021
Q1 | $2.27M | Buy |
+677,500
| New | +$2.27M | 0.54% | 44 |
|
|
2020
Q4 | – | Sell |
-86,082
| Closed | -$164K | – | 85 |
|
|
2020
Q3 | $164K | Hold |
86,082
| – | – | 0.05% | 78 |
|
|
2020
Q2 | $172K | Hold |
86,082
| – | – | 0.05% | 85 |
|
|
2020
Q1 | $88K | Sell |
86,082
-31,600
| -27% | -$32.3K | 0.04% | 78 |
|
|
2019
Q4 | $239K | Buy |
+117,682
| New | +$239K | 0.08% | 78 |
|